LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis
2003
Biochem Pharmacol. 2003 Nov 15;66(10):1885-95. | Preclinical Safety Department, Novartis Pharma AG, WSH.2881.P03, CH-4002 Basel, Switzerland.
Assessment of the skin photoprotective capacities of an organo-mineral broad-spectrum sunblock on two ex vivo skin models
2003
Photodermatol Photoimmunol Photomed. 2003 Oct;19(5):242-53. | Laboratoire des IMRCP, UMR 5623 au CNRS, Université Paul Sabatier, 118 route de Narbonne, 31062 Toulouse Cedex 04, France.
An assessment of the phototoxic hazard of a personal product ingredient using in vitro assays
2003
Toxicol In Vitro. 2003 Aug;17(4):471-80 | Safety and Environmental Assurance Centre, Unilever Colworth, MK44 1LQ, Sharnbrook, Bedfordshire, UK. [email protected]
The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
2003
Infect Immun. 2003 Jun;71(6):3227-34. | Department of Dermatology and Allergology, University of Munich, Germany. [email protected]
Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin
2003
ALTEX. 2003;20(1):3-9. | Institut für Pharmazie, Pharmazie und Toxikologie, Freie Universität Berlin, D-Berlin.
Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner
2002
J Invest Dermatol 2002 ;119 (5):1150-5 | Division of Immunology, Allergy, and Infectious Diseases, Department of Dermatology, University of Vienna Medical School, Austria.
Characterization of the living skin equivalent as a model of cutaneous re-epithelialization
2002
CELL BIOCHEM FUNCT. Cell Biochemistry and Function 2002 ;20 (2):129-141 | Prof. E.J. Wood, Sch. of Biochem./Molecular Biology, University of Leeds, Leeds LS2 9JT EML: [email protected]
Comparison of activities dependent on glutathione S-transferase and cytochrome P-450 IA1 in cultured keratinocytes and reconstructed epidermal models
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):59-67 | Paul Gerson Unna-Skin Research Center, Beiersdorf AG, Hamburg, Germany.
Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or < alpha >-tocopherol applied on human skin models or human skin ex vivo at finite doses
2002
SKIN PHARMACOL APPL SKIN PHYSIOL. Skin Pharmacology and Applied Skin Physiology 2002 ;15 (Suppl. 1):40-58 | F. Dreher, L'Oreal Research, F-93601 Aulnay-sous-Bois EML: [email protected]
Comparison of gene expression profiles in human keratinocyte mono-layer cultures, reconstituted epidermis and normal human skin; transcriptional effects of retinoid treatments in reconstituted human epidermis
2002
Exp Dermatol 2002 ;11 (1):59-74 | BIOalternatives, Gencay, France. [email protected]
A computational skin model: fold and wrinkle formation
2002
IEEE Trans Inf Technol Biomed 2002 ;6 (4):317-23 | MIRAlab, University of Geneva, CH1211 Geneva, Switzerland. [email protected]
Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass for tissue engineering applications
2002
Biomaterials 2002 ;23 (18):3871-8 |
Epidermal-dermal interactions regulate gelatinase activity in ApligrafR, a tissue-engineered human skin equivalent
2002
BR J DERMATOL. British Journal of Dermatology 2002 ;146 (1):26-31 | Dr. P. Schmid, TA Immunopathology/Dermatology, Novartis Pharma Research, 4002 Basel EML: [email protected]
Human epidermis is a novel site of phospholipase B expression
2002
Biochem Biophys Res Commun 2002 ;295 (2):362-9 | Institut de recherche Pierre Fabre, CERPER/Hotel Dieu Saint Jacques, F31052 Toulouse, France.
Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):31-9 | L'Oreal Research, Aulnay-sous-Bois, France. [email protected]
In vitro evaluation of skin sensitivity of povidone-iodine and other antiseptics using a three-dimensional human skin model
2002
Dermatology 2002 ;204 Suppl 1):109-13 | Pharmaceutical Research Center, Meiji Seika Kaisha, Yokohama, Japan. [email protected]
Keratinocytes control the pheo/eumelanin ratio in cultured normal human melanocytes
2002
Pigment Cell Res 2002 ;15 (6):440-6 | L'Oreal Recherche, Clichy, France. [email protected]
Kinetic analysis on the in vitro cytotoxicity using Living Skin Equivalent for ranking the toxic potential of dermal irritants
2002
Toxicol In Vitro 2002 ;16 (6):759-63 | Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan. [email protected]
A long-term coculture model for the study of mast cell-keratinocyte interactions
2002
J Invest Dermatol 2002 ;119 (2):411-5 | Department of Dermatology and Allergy, Humboldt-University, Charite, Berlin, Germany. [email protected]
A new approach to completely autologous cardiovascular tissue in humans
2002
ASAIO J 2002 ;48 (3):234-8 |